Tanja Schirmeister, Dr. rer. nat. habil., Pharmaceutical/Medical Chemistry Specialisation

Pharmacist, Dr. rer. nat. habil., Pharmaceutical/ Medical Chemistry Specialisation

University Professor (W3) of Pharmaceutical and Medicinal Chemistry, Johannes Gutenberg-University Mainz

Google-Scholar

Profile                                                                                       

Current activity:

2011-currentUniversity Professor (W3) of Pharmaceutical and Medicinal Chemistry, Institute for
Pharmaceutical and Biomedical Sciences (IPBW), Department 09,
Chemistry, Pharmacy, Geography and Earth Sciences, Johannes Gutenberg-
University Mainz

 

Academic Education:

1999

Appointment as private lecturer in Pharmaceutical Chemistry
1993 - 1999         Habilitation in Pharmaceutical Chemistry at the Pharmaceutical Institute of the Albert-Ludwigs-University
Freiburg, Synthesis, In vitro testing and structure-activity correlations of new peptidic cysteine protease inhibitors:
The importance of Aziridine dicarboxylic acid building blocks, Mentor Prof. Dr. A.-W. Frahm
1993PhD (Dr. rer. nat.) (magna cum laude), Specialisation: Pharmaceutical Chemistry, Faculty
for Chemistry and Pharmacy, Albert-Ludwigs-University Freiburg.
1989 - 1993PhD thesis Enzymatic Hydrolysis of E/Z-diastereotopic Diesters and E/Z-diastereomers
monoesters at the Pharmaceutical Institute of the University Freiburg with Prof. Dr. H.-H.
Otto.
1988Licence to practise pharmacy
1987 - 1988Pharmacy practical training Bären-Apotheke, March
1982 - 1987       Pharmacy studies, Albert-Ludwigs-University Freiburg

 

Former Activities:

2000 - 2011University Professor (C3) for Pharmaceutical and Medicinal Chemistry at the Institute
for Pharmacy and Food Chemistry at the University Würzburg
2000University lecturer (C2) at the Pharmaceutical Institute of the University Freiburg
1999 - 2002Various lectureships at the Pharmaceutical Institute of the University of Freiburg and at the
Pharmaceutical-Chemical Institute of the University of Heidelberg
1993 - 1999Scientific Assistant (C1) at the Pharmaceutical Chemistry Institute with Prof. Dr.
H.-H. Otto and after his calling to Greifswald with Prof. Dr. A.-W. Frahm,
Pharmaceutical Institute of the University Freiburg
1989 - 1993Scientific staff member at the Pharmaceutical Chemistry Institute with Prof. Dr. H.-
H. Otto, Pharmaceutical Institute of the Albert-Ludwigs-University Freiburg

 

Awards and Honors:

2017            Literature Prize of the Chemical Industry Fund for the  course book „Beyer/Walter,
Organische Chemie“ with C. Schmuck and P. Wich
1999Research award „Eugen-Graetz-Stiftung" of the University Freiburg for the dissertation
1998Habilitation Award of the Division of Medicinal Chemistry of the GDCh and the Division of
Pharmaceutical Chemistry of the DPhG
1993Carl-Wilhelm-Scheele-Award of the German Pharmaceutical Society DPhG for the
Dissertation

Former Activities:

2020 - current   Vice Dean of FB 09 Chemistry, Pharmacy, Geography and Geosciences of the JGU Mainz
2020 - currentHead of the B-Committee (Finances) of FB09 Chemistry, Pharmacy, Geography and Geosciences of the JGU Mainz
2018 - currentMember of the Faculty Council of FB09 Chemistry, Pharmacy, Geography
and Geosciences of the JGU Mainz
2017 - currentMember of the Audit and Review Commissions (Subjects Analytics and Chemistry)
at the Institute for Medical and Pharmaceutical Testing Questions (IMPP) Mainz
2016 - currentMember of the Expert Commission on "General, Inorganic and Organic
Chemistry" at the Institute for Medical and Pharmaceutical Testing Questions (IMPP) Mainz
2015 - heuteChairwoman of the Audit Committee State Examination Pharmacy
2018 - 2021Chairwoman of the Pharmacy Study Committee
2015 - 2021Chairwoman of the A2 Committee (Studies and Teaching) Pharmacy
2015 - 2021Executive Director of the Institute for Pharmaceutical and Biomedical
Sciences (IPBW)
2015 - 2021Deputy Chairwoman of the Apotheker-Jacob-Stiftung
2017 - 2020Member of the Governing Board of the Gutenberg Lectureship College GLK
2013 - 2020Chairwoman of the Prof.-Rochelmeyer-Stiftung
2015 - 2018Member of the Selection Committee of FB 09 for the German National Academic Foundation
2004 - 2016Member of the Expert Commission "Pharmaceutical Analysis" at the Institute for
Medical and Pharmaceutical Examination Questions (IMPP) Mainz
2010 - 2011Chairwoman of the DPhG local group Würzburg

 

Patents (granted):

C. Schmuck, K. Baumann, S. Rohrer, S. Langolf, U. Machon, T. Schirmeister; N-geschützte Guanidinsubstituierte Heteroaromaten als neue Cystein-Protease-Inhibitoren (103.193-3/08); Guanidinocarbonylpyrrole als neue Cystein-Protease-Inhibitoren (103.193-2/08). Deutsche Patentanmeldung DE 10 2008 049 767.3 (29.7.2009). N-geschützte Guanidin-substituierte Furane, Thiophene und Pyrrole als Cystein-Protease-Inhibitoren, 30.09.2009, WO 2010/037536 A1.

Topic specific publications (with Peer Review)

1.  A. Welker, C. Kersten, C. Müller, R. Madhugiri, C. Zimmer, P. Müller, R. Zimmermann, S. Hammerschmidt, H. Maus, J. Ziebuhr, C. Sotriffer, T. Schirmeister, SAR of novel benzamides and isoindolines, designed as SARS-CoV protease inhibitors – effective against SARS-CoV-2. ChemMedChem 2021, 16, 340-354, Cover page, doi: 10.1002/cmdc.202000548; IF: 3.124.

2.  P. Johe, S. Jung, E. Endres, C. Kersten, C. Zimmer, W. Xe, C. Sönnichsen, U. A. Hellmich, C. Sotriffer, T. Schirmeister*, H. Neuweiler*, Warhead reactivity limits the speed of covalent inhibition of the cysteine protease rhodesain. ACS Chemical Biology 2021, 16, 661-670, doi: 10.1021/acschembio.0c00911. IF: 4.434.

3.  P. Johe, E. Jaenicke, H. Neuweiler, T. Schirmeister, C. Kersten*, U. A. Hellmich*; Structure, interdomain dynamics and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes. J. Biol. Chem. 2021, 296, 100565, doi:10.1016/j.jbc.2021.100565 . IF: 4.238.

4.  F. Barthels, G. Marincola, T. Marciniak, M. Konhäuser, S. Hammerschmidt, J. Bierlmeier, U. Distler, P. R. Wich, S. Tenzer, D. Schwarzer, W. Ziebuhr, T. Schirmeister, Asymmetric disulfanylbenzamides as irreversible and selective inhibitors of Staphylococcus aureus Sortase A. ChemMedChem 2020, 15, 839-850, doi: 10.1002/cmdc.201900687. IF: 3.124.

5.  B. Millies, F. v. Hammerstein, A. Gellert, S. Hammerschmidt, F. Barthels, U. Göppel, M. Immerheiser, F. Elgner, N. Jung, M. Basic, C. Kersten, W. Kiefer, J. Bodem, E. Hildt, M. Windbergs, U. A. Hellmich, T. Schirmeister, Proline-based allosteric inhibitors of Zika and Dengue NS2B/NS3 proteases. J. Med. Chem. 2019, 62, 11359-11382, doi: 10.1021/acs.jmedchem.9b01697. IF: 6.205

6.  M. Giroud, U. Dietzel, L. Anselm, D. Banner, J.-B. Blanc, D. Gaufreteau, H. Liu, A. Stich, B. Kuhn, F. Schuler, M. Kaiser, R. Brun, T. Schirmeister, C. Kisker, F. Diederich, W. Haap, Repurposing a human cathepsin L inhibitors library: Identification of macrocyclic lactams as potent rhodesain and Trypanosoma brucei inhibitors, J. Med. Chem. 2018, 61, 3350-3369. doi:1021/acs.jmedchem.7b01869. IF: 6.205.

7.  M. Giroud, B. Kuhn, S. Saint-Auret, C. Kuratli, R. E. Martin, F. Schuler, F. Diederich, M. Kaiser, R. Brun, T. Schirmeister,* W. Haap*, 2H-1,2,3-Triazole-based dipeptidyl nitriles: potent, selective and trypanocidal rhodesain inhibitors by structure-based design. J. Med. Chem. 2018, 61, 3370-3388. doi: 10.1021/acs.jmedchem.7b01870. IF: 6.205.

8.  B. Kuhn, M. Tichý, L. Wang, S. Robinson, R. Martin, A. Kuglstatter, J. Benz, M. Giroud, T. Schirmeister, R. Abel, F. Diederich, J. Hert, Prospective evaluation of free energy calculations for the prioritization of cathepsin L inhibitors. J. Med. Chem. 2017, 60, 2485-2497. doi: 10.1021/acs.jmedchem.6b01881. IF: 6.205.

9.  T. Schirmeister*, J. Kesselring, S. Jung, T. Schneider, A. Weickert, J. Becker, W. Lee, D. Bamberger, P. Wich, U. Distler, S. Tenzer, P. Johé, U. A. Hellmich, B. Engels*, Quantum chemicalbased protocol for the rational design of covalent inhibitors. J. Am. Chem. Soc. 2016, 138, 8332-8335. doi: 10.1021/jacs.6b03052. IF: 14.612

10. H. Wu, S. Bock, M. Snitko, T. Berger, T. Weidner, S. Holloway, M. Kanitz, W. E. Diederich, H. Steuber, C. Walter, D. Hofmann, B. Weißbrich, R. Spannaus, E. G. Acosta, R. Bartenschlager, B. Engels, T. Schirmeister,* J. Bodem, Novel Dengue virus NS2B/NS3 protease inhibitors. Antimicrob. Agents Chemother. 2015, 59, 1100-1109. doi: 10.1128/AAC.03543-14. IF: 4.715